Gain Therapeutics shares owned by Raymond James & Associates
Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Raymond James & Associates
from 13F filings
Historical chart of Raymond James & Associates investment in Gain Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Gain Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Gain Therapeutics by Raymond James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $980k | 260k | 3.77 |
| 2023-12-31 | $78k | 24k | 3.27 |
| 2023-09-30 | $111k | 34k | 3.28 |
| 2023-06-30 | $150k | 33k | 4.48 |
| 2023-03-31 | $96k | 20k | 4.82 |
| 2022-12-31 | $75k | 24k | 3.13 |
| 2022-09-30 | $78k | 24k | 3.25 |
More positions owned by Raymond James & Associates
Home Depot (HD)
View all positions for Raymond James & Associates